FierceBiotech

CEL-SCI Corporation Announces Results of Interim Review of Data from Its Ongoing Phase III Head and Neck Cancer Trial by Independent Data Monitoring Committee (IDMC)

CEL-SCI Corporation Announces Results of Interim Review of Data from Its Ongoing Phase III Head and Neck Cancer Trial by Independent Data Monitoring Committee (IDMC) CEL-SCI Corporation announced ...
Yahoo Finance

OSE Immunotherapeutics Announces Positive Recommendation from Independent Data Monitoring Committee (IDMC) to Continue Pivotal Phase 3 ARTEMIA Trial Evaluating Tedopi® in Non ...

OSE Immunotherapeutics Announces Positive Recommendation from Independent Data Monitoring Committee (IDMC) to Continue Pivotal Phase 3 ARTEMIA Trial Evaluating Tedopi® in Non-Small Cell Lung Cancer ...
Business Wire

Dyne Therapeutics Presents Nonhuman Primate Proof of Concept Data on FORCE™ Therapeutic Platform at International Myotonic Dystrophy Consortium Meeting (IDMC-12)

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dyne Therapeutics, a biotechnology company pioneering targeted therapies for patients with serious muscle diseases, today announced preclinical data at the 12th ...